393 related articles for article (PubMed ID: 37827483)
1. Endocrine-disrupting chemicals and male reproductive health.
Mínguez-Alarcón L; Gaskins AJ; Meeker JD; Braun JM; Chavarro JE
Fertil Steril; 2023 Dec; 120(6):1138-1149. PubMed ID: 37827483
[TBL] [Abstract][Full Text] [Related]
2. Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children.
Midya V; Colicino E; Conti DV; Berhane K; Garcia E; Stratakis N; Andrusaityte S; Basagaña X; Casas M; Fossati S; Gražuleviciene R; Haug LS; Heude B; Maitre L; McEachan R; Papadopoulou E; Roumeliotaki T; Philippat C; Thomsen C; Urquiza J; Vafeiadi M; Varo N; Vos MB; Wright J; McConnell R; Vrijheid M; Chatzi L; Valvi D
JAMA Netw Open; 2022 Jul; 5(7):e2220176. PubMed ID: 35793087
[TBL] [Abstract][Full Text] [Related]
3. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
[TBL] [Abstract][Full Text] [Related]
4. Effects of bisphenol A on male and couple reproductive health: a review.
Mínguez-Alarcón L; Hauser R; Gaskins AJ
Fertil Steril; 2016 Sep; 106(4):864-70. PubMed ID: 27498136
[TBL] [Abstract][Full Text] [Related]
5. Exposure to phthalates and female reproductive health: A literature review.
Basso CG; de Araújo-Ramos AT; Martino-Andrade AJ
Reprod Toxicol; 2022 Apr; 109():61-79. PubMed ID: 35248714
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-Disrupting Chemicals and Reproductive Health.
Zlatnik MG
J Midwifery Womens Health; 2016 Jul; 61(4):442-55. PubMed ID: 27391253
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to endocrine disrupting chemicals and fertility: A case-control study in male subfertility patients.
Den Hond E; Tournaye H; De Sutter P; Ombelet W; Baeyens W; Covaci A; Cox B; Nawrot TS; Van Larebeke N; D'Hooghe T
Environ Int; 2015 Nov; 84():154-60. PubMed ID: 26292060
[TBL] [Abstract][Full Text] [Related]
8. Exposure to non-persistent chemicals in consumer products and fecundability: a systematic review.
Hipwell AE; Kahn LG; Factor-Litvak P; Porucznik CA; Siegel EL; Fichorova RN; Hamman RF; Klein-Fedyshin M; Harley KG;
Hum Reprod Update; 2019 Jan; 25(1):51-71. PubMed ID: 30307509
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations.
Ruiz D; Becerra M; Jagai JS; Ard K; Sargis RM
Diabetes Care; 2018 Jan; 41(1):193-205. PubMed ID: 29142003
[TBL] [Abstract][Full Text] [Related]
10. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.
Ding N; Harlow SD; Randolph JF; Loch-Caruso R; Park SK
Hum Reprod Update; 2020 Sep; 26(5):724-752. PubMed ID: 32476019
[TBL] [Abstract][Full Text] [Related]
11. Association of Preterm Birth and Exposure to Endocrine Disrupting Chemicals.
Kolan AS; Hall JM
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768276
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
13. Exposure to modern, widespread environmental endocrine disrupting chemicals and their effect on the reproductive potential of women: an overview of current epidemiological evidence.
Karwacka A; Zamkowska D; Radwan M; Jurewicz J
Hum Fertil (Camb); 2019 Apr; 22(1):2-25. PubMed ID: 28758506
[TBL] [Abstract][Full Text] [Related]
14. Integrating -omics approaches into population-based studies of endocrine disrupting chemicals: A scoping review.
Maitre L; Jedynak P; Gallego M; Ciaran L; Audouze K; Casas M; Vrijheid M
Environ Res; 2023 Jul; 228():115788. PubMed ID: 37004856
[TBL] [Abstract][Full Text] [Related]
15. Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study.
Woods MM; Lanphear BP; Braun JM; McCandless LC
Environ Health; 2017 Oct; 16(1):115. PubMed ID: 29078782
[TBL] [Abstract][Full Text] [Related]
16. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disrupting chemicals: Impacts on human fertility and fecundity during the peri-conception period.
Green MP; Harvey AJ; Finger BJ; Tarulli GA
Environ Res; 2021 Mar; 194():110694. PubMed ID: 33385395
[TBL] [Abstract][Full Text] [Related]
18. Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models.
Laws MJ; Neff AM; Brehm E; Warner GR; Flaws JA
Adv Pharmacol; 2021; 92():151-190. PubMed ID: 34452686
[TBL] [Abstract][Full Text] [Related]
19. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.
Newbold RR
Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1939S-1942S. PubMed ID: 22089436
[TBL] [Abstract][Full Text] [Related]
20. Impact of endocrine-disrupting chemicals on steroidogenesis and consequences on testicular function.
Walker C; Garza S; Papadopoulos V; Culty M
Mol Cell Endocrinol; 2021 May; 527():111215. PubMed ID: 33657436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
